DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Dr Reddys Share Price Live Updates: Dr. Reddys Market Activity Overview

Economic Times 3 hrs ago·1 Oct 2026, 3:21 am

Dr. Reddy's Laboratories is currently seeing significant market activity, with its share price fluctuating throughout the trading day. Investors are closely watching the stock as it moves, reflecting a mix of broader market trends and company-specific developments. The volatility indicates active trading and varying investor sentiment towards the pharmaceutical giant.

This movement is particularly important for investors as it signals a period of heightened interest and potential shifts in market perception. The stock's performance today could provide clues about future trends in the pharmaceutical sector and the company's current standing in the market.

Investors should keep an eye on the stock's direction as the session progresses. Any significant changes in volume or price movement could indicate upcoming news or market reactions that might impact the company's valuation in the coming days.